Sarepta Therapeutics, Inc.
SRPT
$20.22
$0.160.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 800.14M | 522.76M | 1.35B | 1.20B | 1.46B |
| Total Receivables | 609.60M | 724.52M | 649.73M | 515.99M | 392.26M |
| Inventory | 994.04M | 941.43M | 749.96M | 565.92M | 485.80M |
| Prepaid Expenses | 34.26M | 29.31M | 30.67M | 31.54M | 34.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 218.96M | 214.51M | 288.32M | 373.53M | 310.87M |
| Total Current Assets | 2.66B | 2.43B | 3.07B | 2.69B | 2.68B |
|
|
|||||
| Total Current Assets | 2.66B | 2.43B | 3.07B | 2.69B | 2.68B |
| Net Property, Plant & Equipment | 514.90M | 507.65M | 488.65M | 446.69M | 400.20M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 30.52M | 26.20M | 26.89M | 27.57M | 28.25M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 247.28M | 387.41M | 237.30M | 253.82M | 304.56M |
| Total Assets | 3.68B | 3.47B | 3.96B | 3.60B | 3.42B |
|
|
|||||
| Total Accounts Payable | 136.70M | 156.11M | 214.44M | 118.77M | 107.42M |
| Total Accrued Expenses | 205.24M | 178.77M | 241.66M | 216.59M | 206.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.42M | 12.97M | 13.27M | 108.88M | 108.63M |
| Total Finance Division Other Current Liabilities | 567.59M | 257.74M | 262.31M | 255.24M | 266.04M |
| Total Other Current Liabilities | 567.59M | 257.74M | 262.31M | 255.24M | 266.04M |
| Total Current Liabilities | 919.95M | 605.59M | 731.68M | 699.49M | 688.49M |
|
|
|||||
| Total Current Liabilities | 919.95M | 605.59M | 731.68M | 699.49M | 688.49M |
| Long-Term Debt | 1.14B | 1.14B | 1.14B | 1.14B | 1.13B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 214.42M | 205.46M | 192.47M | 170.01M | 143.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.60M | 373.33M | 374.15M | 373.40M | 380.29M |
| Total Liabilities | 2.32B | 2.32B | 2.44B | 2.38B | 2.35B |
|
|
|||||
| Common Stock & APIC | 5.84B | 5.80B | 5.74B | 5.59B | 5.48B |
| Retained Earnings | -4.46B | -4.66B | -4.21B | -4.37B | -4.40B |
| Treasury Stock & Other | -25.31M | 34.00K | -218.00K | 2.25M | -1.03M |
| Total Common Equity | 1.36B | 1.14B | 1.53B | 1.22B | 1.08B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.36B | 1.14B | 1.53B | 1.22B | 1.08B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.36B | 1.14B | 1.53B | 1.22B | 1.08B |
|
|
|||||